Fludarabine/Cyclophosphamide/Rituxan is an effective regimen for non-myeloablative allogeneic stem cell transplantation (SCT) for lymphoid malignancies.

被引：0
|
作者：
Berkahn, LC [1 ]
Simpson, DR [1 ]
Raptis, A [1 ]
Klingemann, HG [1 ]
机构：
[1] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5274
引用
收藏
页码：352B / 352B
页数：1
相关论文
共 50 条
  • [31] LOW Tranplant Related Mortality and LOW GRAFT Rejection After Related Haploidentical STEM CELL Transplantation (HAPLO-SCT) Prepared with NON Myeloablative CONDITIONING REGIMEN (NMA) and Posttransplant Cyclophosphamide for Advanced Lymphoid Malignancies.
    Furst, Sabine
    Crocchiolo, Roberto
    El-Cheikh, Jean
    Faucher, Catherine
    Oudin, Claire
    Granata, Angela
    Venton, Geoffroy
    Lemarie, Claude
    Coso, Diane
    Bouabdallah, Reda
    Stoppa, Anne Marie
    Vey, Norbert
    Chabannon, Christian
    Blaise, Didier
    BLOOD, 2012, 120 (21)
  • [32] Non-Myeloablative Stem Cell Transplantation
    Robert Marcus
    Bone Marrow Transplantation, 2001, 27 (6) : 667 - 667
  • [33] Allogeneic stem cell transplantation after non myeloablative conditioning for poor risk patients with hematologic malignancies.
    Dentamaro, T
    Cudillo, L
    Picardi, A
    Rainaldi, A
    Cox, MC
    Catalano, GF
    Adorno, G
    Piccioni, D
    Masi, M
    Tamburini, A
    Buccisano, F
    Amadori, S
    BONE MARROW TRANSPLANTATION, 1998, 21 : S101 - S101
  • [34] Allogeneic non-myeloablative stem cell transplantation for refractory rheumatoid arthritis
    Burt, R
    Oyama, Y
    Barr, W
    Traynor, A
    BONE MARROW TRANSPLANTATION, 2003, 31 : S145 - S146
  • [35] Thiotepa, Busulfan and Fludarabine Conditioning Regimen in Adult Patients Undergoing Allogeneic Stem Cell Transplantation for Lymphoid Malignancies. a Study on Behalf of Geth-TC
    Pena, Marta
    Paviglianiti, Annalisa
    Jesus Pascual, Maria
    Herruzo, Beatriz
    Solano, Carlos
    Benzaquen, Ana
    Queralt Salas, Maria
    Rovira, Montserrat
    Agustin Nieto
    Espanol, Ignacio
    Marin, Adolfo Jesus Saez
    Bento De Miguel, Leyre
    Sureda Balari, Anna Maria
    Mussetti, Alberto
    BLOOD, 2023, 142
  • [36] Comparable risk of cytomegalovirus infection after allogeneic haematopoietic stem cell transplantation following non-myeloablative or myeloablative preparative regimen in patients affected by haematologic malignancies
    Caldera, D
    Lilleri, D
    Bernasconi, P
    Colombo, A
    Montanari, F
    Ardizzone, F
    Parea, M
    Lazzarino, M
    Gerna, G
    Alessandrino, E
    BONE MARROW TRANSPLANTATION, 2004, 33 : S198 - S199
  • [37] Allogeneic stem cell transplantation using non-myeloablative transplant regimens
    Körbling, M
    Khouri, I
    HIGH-DOSE THERAPY AND TRANSPLANTATION OF HAEMATOPOIETIC STEM CELLS, 2000, : 175 - 184
  • [38] Non-myeloablative allogeneic stem cell transplantation for metastatic renal cell carcinoma
    Yun, Tak
    Lee, Keun-Wook
    Song, Eun-Gi
    Na, Im-Il
    Shin, Hyun-Chun
    Yoon, Sung-Soo
    Park, Seon-Yang
    Kim, Byoung-Kook
    Lee, Jung-Hee
    Choi, Seong-Jun
    Lee, Je-Hwan
    Lee, Kyoo-Hyung
    CLINICAL TRANSPLANTATION, 2007, 21 (03) : 337 - 343
  • [39] Non-myeloablative allogeneic stem cell transplantation for metastatic renal cell carcinoma
    Bahnson, R
    Hu, HS
    Vogelzang, NJ
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2003, 21 (01) : 79 - 81
  • [40] A fludarabine-based non-myeloablative conditioning regimen in allogeneic stem cell transplantation from related and unrelated donors in chronic myeloid leukemia.
    Luo, Yi
    Huang, He
    Cai, Zhen
    Tan, Yamin
    Han, Xiaoyan
    BLOOD, 2006, 108 (11) : 436B - 436B
12345